Literature DB >> 1372813

Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma.

T J Torphy1, G P Livi, J M Balcarek, J R White, F H Chilton, B J Undem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1372813

Source DB:  PubMed          Journal:  Adv Second Messenger Phosphoprotein Res        ISSN： 1040-7952


× No keyword cloud information.
  8 in total

1.  Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.

Authors:  Jackie D Corbin; Roya Zoraghi; Sharron H Francis
Journal:  Cell Signal       Date:  2009-08-06       Impact factor: 4.315

2.  Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.

Authors:  M Grous; M Barnette
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

3.  Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.

Authors:  D E Griswold; E F Webb; J Breton; J R White; P J Marshall; T J Torphy
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

4.  Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.

Authors:  J E Souness; C Maslen; S Webber; M Foster; D Raeburn; M N Palfreyman; M J Ashton; J A Karlsson
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 5.  Cyclic nucleotide phosphodiesterases in the human lung.

Authors:  G Dent; H Magnussen; K F Rabe
Journal:  Lung       Date:  1994       Impact factor: 2.584

Review 6.  Clinical Implication of Phosphodiesterase-4-Inhibition.

Authors:  Martin Alexander Schick; Nicolas Schlegel
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

7.  Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.

Authors:  T J Torphy; M S Barnette; D W Hay; D C Underwood
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

8.  Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitors.

Authors:  K L Molnar-Kimber; L Yonno; R J Heaslip; B M Weichman
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.